(Total Views: 370)
Posted On: 05/20/2021 12:08:35 PM
Post# of 148900
Re: craigakess #91070
I agree, It is not great that this company is reactionary rather than being proactive. When the CD12 (and CD10) trials had approved protocols, I think everyone assumed we just needed to complete them and we are a covid drug company. Not many even thought what happens if we fail these trials. We can be optimistic, management should have a plan for the worst case scenario. We could have recruited more than the trial required, we could have had a more detailed DSMC review and we should have stood our ground on the 2 dose limit.
(2)
(0)
Scroll down for more posts ▼